These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 15546804

  • 1. Drug discovery and chemokine receptor antagonists: eppur si muove!
    Terricabras E, Benjamim C, Godessart N.
    Autoimmun Rev; 2004 Nov; 3(7-8):550-6. PubMed ID: 15546804
    [Abstract] [Full Text] [Related]

  • 2. Chemokine receptors: attractive targets for drug discovery.
    Godessart N.
    Ann N Y Acad Sci; 2005 Jun; 1051():647-57. PubMed ID: 16127005
    [Abstract] [Full Text] [Related]

  • 3. CCR1 antagonists for the treatment of autoimmune diseases.
    Gladue RP, Zwillich SH, Clucas AT, Brown MF.
    Curr Opin Investig Drugs; 2004 May; 5(5):499-504. PubMed ID: 15202722
    [Abstract] [Full Text] [Related]

  • 4. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X, Oppenheim JJ, Howard OM.
    Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
    [Abstract] [Full Text] [Related]

  • 5. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
    Vielhauer V, Anders HJ, Schlöndorff D.
    Semin Nephrol; 2007 Jan; 27(1):81-97. PubMed ID: 17336691
    [Abstract] [Full Text] [Related]

  • 6. Promiscuous drugs as therapeutics for chemokine receptors.
    Horuk R.
    Expert Rev Mol Med; 2009 Jan 06; 11():e1. PubMed ID: 19123963
    [Abstract] [Full Text] [Related]

  • 7. Current status of chemokine receptor inhibitors in development.
    Allegretti M, Cesta MC, Garin A, Proudfoot AE.
    Immunol Lett; 2012 Jul 30; 145(1-2):68-78. PubMed ID: 22698186
    [Abstract] [Full Text] [Related]

  • 8. Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists?
    Russo RC, Garcia CC, Teixeira MM.
    Curr Opin Drug Discov Devel; 2010 Jul 30; 13(4):414-27. PubMed ID: 20597027
    [Abstract] [Full Text] [Related]

  • 9. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.
    Haringman JJ, Oostendorp RL, Tak PP.
    Expert Opin Emerg Drugs; 2005 May 30; 10(2):299-310. PubMed ID: 15934868
    [Abstract] [Full Text] [Related]

  • 10. The expression and function of chemokines involved in CNS inflammation.
    Ubogu EE, Cossoy MB, Ransohoff RM.
    Trends Pharmacol Sci; 2006 Jan 30; 27(1):48-55. PubMed ID: 16310865
    [Abstract] [Full Text] [Related]

  • 11. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics.
    Suresh P, Wanchu A.
    J Postgrad Med; 2006 Jan 30; 52(3):210-7. PubMed ID: 16855325
    [Abstract] [Full Text] [Related]

  • 12. Chemokine blockers--therapeutics in the making?
    Wells TN, Power CA, Shaw JP, Proudfoot AE.
    Trends Pharmacol Sci; 2006 Jan 30; 27(1):41-7. PubMed ID: 16310864
    [Abstract] [Full Text] [Related]

  • 13. Allosteric inhibitors of chemoattractant receptors: opportunities and pitfalls.
    Allegretti M, Bertini R, Bizzarri C, Beccari A, Mantovani A, Locati M.
    Trends Pharmacol Sci; 2008 Jun 30; 29(6):280-6. PubMed ID: 18423629
    [Abstract] [Full Text] [Related]

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 30; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 15. The chemokine network: a target in cancer biology?
    Slettenaar VI, Wilson JL.
    Adv Drug Deliv Rev; 2006 Oct 01; 58(8):962-74. PubMed ID: 16996642
    [Abstract] [Full Text] [Related]

  • 16. The clinical potential of chemokine receptor antagonists.
    Ribeiro S, Horuk R.
    Pharmacol Ther; 2005 Jul 01; 107(1):44-58. PubMed ID: 15894378
    [Abstract] [Full Text] [Related]

  • 17. Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3.
    Johnson M, Li AR, Liu J, Fu Z, Zhu L, Miao S, Wang X, Xu Q, Huang A, Marcus A, Xu F, Ebsworth K, Sablan E, Danao J, Kumer J, Dairaghi D, Lawrence C, Sullivan T, Tonn G, Schall T, Collins T, Medina J.
    Bioorg Med Chem Lett; 2007 Jun 15; 17(12):3339-43. PubMed ID: 17448658
    [Abstract] [Full Text] [Related]

  • 18. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.
    Ali S, O'Boyle G, Mellor P, Kirby JA.
    Mol Immunol; 2007 Mar 15; 44(7):1477-82. PubMed ID: 17000001
    [Abstract] [Full Text] [Related]

  • 19. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH, Tebben AJ.
    Methods Enzymol; 2009 Mar 15; 461():249-79. PubMed ID: 19480923
    [Abstract] [Full Text] [Related]

  • 20. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.
    Donnelly LE, Barnes PJ.
    Trends Pharmacol Sci; 2006 Oct 15; 27(10):546-53. PubMed ID: 16911834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.